Effect of a single IV infusion of zoledronic acid on bone turnover markers versus oral risedronate in patients with glucocorticoid-induced osteoporosis

被引：0
|
作者：
Sambrook, P.
Devogelaer, J.
Reginster, J.
Saag, K.
Roux, C.
Lau, C.
Papanastasiou, P.
Schoenborn-Kellenberger, O.
Maylandt, K.
Fashola, T.
Mesenbrink, P.
Reid, D.
机构：
[1] Univ Sydney, Sydney, NSW 2006, Australia
[2] Catholic Univ Louvain, B-1200 Brussels, Belgium
[3] Univ Liege, Liege, Belgium
[4] Univ Alabama Birmingham, Birmingham, AL USA
[5] Paris Descartes Univ, Paris, France
[6] Univ Dundee, Dundee, Scotland
[7] Novartis Pharma AG, Basel, Switzerland
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Univ Aberdeen, Aberdeen, Scotland
来源：
BONE | 2009年 / 44卷
关键词：
D O I：
10.1016/j.bone.2009.01.213
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
297
引用
收藏
页码：S94 / S95
页数：2
相关论文
共 50 条
  • [1] EFFECT OF SINGLE ANNUAL INFUSION OF ZOLEDRONIC ACID ON BONE TURNOVER MARKERS VERSUS DAILY ORAL RISEDRONATE IN PATIENTS WITH GLUCOCORTICOID-INDUCED OSTEOPOROSIS
    Sambrook, P.
    Reid, D.
    Devogelaer, J. -P.
    Reginster, J. -Y.
    Saag, K.
    Roux, C.
    Papanastasiou, P.
    Maylandt, K.
    Fashola, T.
    Mesenbrink, P.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 128 - 129
  • [2] Effect of a aingle i.v. infusion of zoledronic acid on bone turnover markers versus oral risedronate in patients with glucocorticoid-induced osteoporosis
    Sambrook, P.
    Devogelaer, J.
    Reginster, J.
    Saag, K.
    Roux, C.
    Lau, C.
    Papanastasiou, P.
    Schoenborn-Kellenberger, O.
    Maylandt, K.
    Fashola, T.
    Mesenbrink, P.
    Reid, D.
    BONE, 2009, 44 : S96 - S96
  • [3] Effect of a Single 5-mg Infusion of Zoledronic Acid on Bone Turnover Markers Versus Oral Risedronate (5 mg/day) Over 1 Year in Patients with Glucocorticoid-Induced Osteoporosis.
    Sambrook, P.
    Devogelaer, J.
    Reginster, J.
    Saag, K.
    Roux, C.
    Lau, C.
    Papanastasiou, P.
    Schoenborn-Kellenberger, O.
    Maylandt, K.
    Fashola, T.
    Mesenbrink, P.
    Reid, D.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S464 - S464
  • [4] Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis
    Roux, C.
    Reid, D. M.
    Devogelaer, J. -P.
    Saag, K.
    Lau, C. S.
    Reginster, J. -Y.
    Papanastasiou, P.
    Bucci-Rechtweg, C.
    Su, G.
    Sambrook, P. N.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 (03) : 1083 - 1090
  • [5] Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis
    C. Roux
    D. M. Reid
    J.-P. Devogelaer
    K. Saag
    C. S. Lau
    J.-Y. Reginster
    P. Papanastasiou
    C. Bucci-Rechtweg
    G. Su
    P. N. Sambrook
    Osteoporosis International, 2012, 23 : 1083 - 1090
  • [6] Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids
    Devogelaer, Jean-Pierre
    Sambrook, Philip
    Reid, David M.
    Goemaere, Stefan
    Ish-Shalom, Sophia
    Collette, Julien
    Su, Guoqin
    Bucci-Rechtweg, Christina
    Papanastasiou, Philemon
    Reginster, Jean-Yves
    RHEUMATOLOGY, 2013, 52 (06) : 1058 - 1069
  • [7] Bone histomorphometry analyses in glucocorticoid-induced osteoporosis patients treated with once-yearly zoledronic acid or oral risedronate over 1 year
    Recker, R.
    Reid, D.
    Papanastasiou, P.
    Chappard, D.
    BONE, 2011, 48 : S205 - S205
  • [8] Correlations between bone turnover markers and BMD in patients treated with teriparatide or alendronate for glucocorticoid-induced osteoporosis
    Burshell, A. L.
    Moericke, R.
    Correa-Rotter, R.
    Chen, P.
    Warner, M. R.
    Krege, J. H.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S128 - S128
  • [9] PREFERENCE AND EFFICACY OF ZOLEDRONIC ACID FOR THE TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS IN PATIENTS WITH AUTOIMMUNE
    Kim, J. W.
    Kim, H. A.
    Jung, J. Y.
    Suh, C. H.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S130 - S130
  • [10] Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis
    Serefoglu, Ege Can
    Tandogdu, Zafer
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 219 - 223
12345